Past Events

Events which have already happened.

Automated High-Throughput qPCR Solutions Oct 06, 2011 from 02:30 PM to 03:30 PM 1131 Bioinformatics Bldg.,
A Special Presentation on Genomics Research Technologies
Next-Generation PostLight Sequencing with Semiconductor Chips Sep 27, 2011 from 03:00 PM to 04:00 PM 1131 Bioinformatics Building,
We invite you to join Dr. Jeremy Stuart of Life Technologies, to discuss next-generation PostLight™ sequencing with semiconductor chips. Ion Torrent has developed the world’s first semiconductor-based DNA sequencing technology, directly translating chemical information into digital data. DNA sequencing is performed with all natural nucleotides on Ion’s proprietary semiconductor chips, leveraging a billion years of evolution and a trillion dollars of investment to allow unprecedented scalability, speed, and costs according to Moore’s Law. Because Ion Torrent technology doesn't use light, it vastly reduces the cost and time of sequencing while still delivering next-generation sequencing throughputs. This may democratize the field of next-generation sequencing and have important implications for clinical, diagnostic, and research applications in which speed is of paramount significance.
Quarterly Core Directors Meeting Sep 21, 2011 from 03:00 PM to 04:30 PM 219 Brinkhous-Bullitt,
Mass Spectrometry-Based Tissue Imaging Sep 14, 2011 from 09:00 AM to 03:00 PM 321 MacNider Hall,
MALDI-Imaging Mass-spectrometry (IMS) is a novel technique at the forefront of imaging-based scientific research. This technique allows the acquisition of “Molecular” images for any tissue based on the distribution of proteins, lipids or small molecules. With extensive application to basic and clinical research, IMS is becoming a powerful tool for diagnosis and for biomarker discovery. This conference will reunite world-leaders in IMS who will present their personal experiences on this field, including applications to basic and clinical sciences, both for diagnoses and biomarker discovery. Scientists of all fields are welcome to attend. Special emphasis will be placed on the use of IMS for cancer research.
Quarterly Core Directors Meeting Jun 22, 2011 from 03:00 PM to 04:30 PM 219 Brinkhous-Bullitt,